Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C, Nicholson G, Gonzalez-Neira A, Martin M, Sargent D, Green E, McLeod H, Zanger UM, Schwab M, Braun M, Seymour M, Thompson L, Lacas B, Boige V, Ribelles N, Afzal S, Enghusen H, Jensen SA, Etienne-Grimaldi MC, Milano G, Wadelius M, Glimelius B, Garmo H, Gusella M, Lecomte T, Laurent-Puig P, Martinez-Balibrea E, Sharma R, Garcia-Foncillas J, Kleibl Z, Morel A, Pignon JP, Midgley R, Kerr D, Tomlinson I. Rosmarin D, et al. Among authors: lecomte t. J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857. Epub 2014 Mar 3. J Clin Oncol. 2014. PMID: 24590654 Free PMC article. Review.
Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma.
Taïeb J, Mitry E, Boige V, Artru P, Ezenfis J, Lecomte T, Clavero-Fabri MC, Vaillant JN, Rougier P, Ducreux M. Taïeb J, et al. Among authors: lecomte t. Ann Oncol. 2002 Aug;13(8):1192-6. doi: 10.1093/annonc/mdf201. Ann Oncol. 2002. PMID: 12181241 Free article. Clinical Trial.
[5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
Taïeb J, Lecomte T, Ezenfis J, Artru P, Mitry E, Boige V, Clavero-Fabri MC, Vaillant JN, Rougier P, Ducreux M. Taïeb J, et al. Among authors: lecomte t. Gastroenterol Clin Biol. 2002 Jun-Jul;26(6-7):605-9. Gastroenterol Clin Biol. 2002. PMID: 12193860 Free article. Clinical Trial. French.
[Matrix metalloproteinases and gastrointestinal tract cancers].
Zinzindohoué F, Lecomte T, Laurent-Puig P. Zinzindohoué F, et al. Among authors: lecomte t. Gastroenterol Clin Biol. 2005 Apr;29(4):434-44. doi: 10.1016/s0399-8320(05)80799-7. Gastroenterol Clin Biol. 2005. PMID: 15864209 Free article. Review. French. No abstract available.
Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis.
Thariat J, Azzopardi N, Peyrade F, Launay-Vacher V, Santini J, Lecomte T, Etienne-Grimaldi MC, Paintaud G, Milano G. Thariat J, et al. Among authors: lecomte t. J Clin Oncol. 2008 Sep 1;26(25):4223-5. doi: 10.1200/JCO.2008.18.7674. J Clin Oncol. 2008. PMID: 18757343 No abstract available.
387 results